CALV-P study

The evaluation of the effects of CAsein hydroLysate containing milk-derived peptides on Vascular function and blood pressure in subjects with Prehypertension - CALV-P study

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-jRCTs071180030

Enrollment

Registered

2019-03-05

Start date

2018-09-12

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Prehypertension (casual blood pressure = 120-139/80-89 mmHg)

Interventions

The effect of functional food/placebo prescribed for 8 weeks on blood pressure is examined.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Prehypertension (casual blood pressure = 120-139/80-89 mmHg)

Exclusion criteria

Exclusion criteria: Hypertension(casual blood pressure >140/90 mmHg) Patients with cardiovascular disease Allergy for milk Atrial fibrillation Current smoker Taking food lowering blood pressure

Design outcomes

Primary

Measure	Time frame
blood pressure	—

Secondary

Measure	Time frame
vascular function (pulse wave velocity, pulse wave analysis, endothelial function)	—

Contacts

Public ContactHirofumi Tamiyama

Tokyo Medical University

tomiyama@tokyo-med.ac.jp+81-3-3342-6111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026